MiNK Therapeutics Inc (NASDAQ:INKT) does about 50.53K shares in volume on a normal day but saw 588421 shares change hands in the recent trading day. The company now has a market cap of 26.81M USD. Its current market price is $0.68, marking a decrease of -4.52% compared to the previous close of $0.71. The 52 week high reached by this stock is $1.90 whilst the lowest price level in 52 weeks is $0.71.
MiNK Therapeutics Inc (INKT) has a 20-day trading average at $0.7454 and the current price is -64.32% off the 52-week high compared with -4.52% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.7946 and its 200-day simple moving average is $0.9135. If we look at the stock’s price movements over the week, volatility stands at 8.97%, which decreases to 5.65% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 28.10 to suggest the stock is oversold.
The consensus objective for the share price is $8.50, suggesting that the stock has a potential upside of 92.0% over the period.
The current price level is -9.04%, -14.67%, and -25.78% away from its SMA20, SMA50, and SMA200 respectively, with the INKT price moving above the 50-day SMA on current market day. MiNK Therapeutics Inc (INKT) stock is down -7.76% over the week and -15.04% over the past month. Its price is -36.64% year-to-date and -42.05% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of -0.15 above consensus estimates by 0.03. The company’s next earnings report forecasts estimating quarterly EPS at -0.08 and -0.34 for whole year.
To reach the target analysts have set, the stock logically needs to grow 92.0 percent from here.
Outstanding shares total 34.60M with insiders holding 74.67% of the shares and institutional holders owning 2.39% of the company’s common stock. The beta has a value of 0.05.
